Literatur
Miehlke S, Guagnozzi D, Abdo YZ et al. European guidelines on Microscopic Colitis: United European Gastroenterology (UEG) and European Microscopic Colitis Group EMCG recommendations. United European Gastroenterol J. 2020 Aug 20:2050640620951905 doi: 10.1177/2050640620951905. Online ahead of print.
Tong J, Zheng Q, Zhang C et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol 2015;110:265-76
Jaruvongvanich V, Poonsombudlert K and Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis 2019;25:672-8
Miehlke S et al. Microscopic Colitis: Pathophysiology and Clinical Management. Lancet Gastroenterol Hepatol 2019;4:305-31
Hjortswang H, Tysk C, Bohr J et al. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis 2011;43:102-9
Verhaegh B, Münch A, Guagnozzi D et al. Course of disease in patients with microscopic colitis - a European prospective incident cohort study. J Crohn's Colitis 2021, im Druck.
Marlicz W et al. Endoscopic findings and colonic perforation in microscopic colitis: a systematic review. Dig Liver Dis 2017;49:1073-85
Kanstrup-Fiehn AM, Miehlke S, Aust D et al. Distribution of Histopathological Features along the Colon in Microscopic Colitis. Int J Colorectal Dis 2020 Sep 12. doi: 10.1007/s00384-020-03747-z. Online ahead of print.
Pisani LF, Tontini GE, Marinoni B, et al. Biomarkers and microscopic colitis: an unmet need in clinical practice. Front Med (Lausanne) 2017;4:54. doi: 10.3389/fmed.2017.00054.
Wildt S, Munck LK, Becker S et al. Risk of osteoporosis in microscopic colitis. Postgrad Med 2018;130:348-54
Miehlke S, Madisch A, Kupcinskas L et al. Budesonide is more effective than mesalamine or placebo in short- term treatment of collagenous colitis. Gastroenterology 2014;146:1222-30
Miehlke S, Aust D, Mihaly E et al. Efficacy and safety of budesonide, vs mesalazine or placebo, as induction therapy for lymphocytic colitis. Gastroenterology 2018;155:1795-804
Pardi DS et al. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology 2001;120:1483-4
Vennamaneni SR, Bonner GF. Use of azathioprine or 6-mercaptopurine for treatment of steroid-dependent lymphocytic and collagenous colitis. Am J Gastroenterol 2001;96:2798-9
Esteve M, Mahadevan U, Sainz E et al. Efficacy of anti- TNF therapies in refractory severe microscopic colitis. J Crohns Colitis 2011;5:612-8
Münch A et al. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol 2012; 47: 59-63
Münch A, Fernandez-Banares F and Munck LK. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis. Aliment Pharmacol Ther 2013;37:795-8
Cotter TG, Kamboj AK, Hicks SB, et al. Immune modulator therapy for microscopic colitis in a case series of 73 patients. Aliment Pharmacol Ther 2017;46:169-74
Riviere P, Munch A, Michetti P et al. Vedolizumab in refractory microscopic colitis: an international case series. J Crohns Colitis 2019;13:337-40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miehlke, S. Erste europäische Leitlinie zur mikroskopischen Kolitis. Gastro-News 8, 44–47 (2021). https://doi.org/10.1007/s15036-021-2289-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15036-021-2289-x